The stock of Tiziana Life Sciences PLC (NASDAQ:TLSA) is now priced at $6.99 and the shares are -5.38 points down or -43.49% lower compared to its previous closing price of $12.37. The stock had 29.791 million contracts set over the past session. TLSA shares’ daily volume is compared to its average trading volume at 0.303 million shares. However, it has a float of 10.11 million and although its performance was -25.24% over the week, it’s one to watch. It means the stock’s downside potential is -100% with the TLSA share price recently placing at $5.9 to $12.17. However, some brokerage firms have priced the stock below the average, including one that has called $25.
The shorts are climbing into the Tiziana Life Sciences PLC stock, with the latest data on short interest released on July 15, 2020, showing that short interest numbers in the TLSA shares have risen. Short interest in the stock represents just 0.63% of its float, but the volume has raised by 49220. The volume of shorted shares rised to 63566 from 14346 shares over the last two weeks. The average intraday trading volume has been 147911 shares, which means that days to cover moved to roughly 1.
In the last trading session, Tiziana Life Sciences PLC (NASDAQ:TLSA) raised by $3.25 over the week and gained $4.39 on its 20-day. The stock’s high in the recent session is lower when compared to its 52-week high of $12.17. The stock recorded its established 52-week high on 07/31/20.
Since 02/24/20, the stock has traded to a low of $0.62 at 353.9%, an encouraging piece of data likely to interest most investors out to exploit the stock’s recent surge.
Looking at current readings, Tiziana Life Sciences PLC’s two-week RSI is 43.34. This suggests that the stock is neutral at the moment and that TLSA shares’ price movement remains stable. The stochastic readings are equally revealing at 50.81% meaning the TLSA share price is currently in neutral territory.
The technical chart shows that the TLSA stock will likely settle at between $10.81 and $14.62 per share. However, if the stock dips below $4.54, then its market would become much weaker. Any downside could see the stock price sliding to levels as low as $2.08.
Currently, the stock is trading in the green of MACD, with a reading of 0.92. Investors always pay attention to any move above or below the zero-line, mainly because the indicator points to the position of the stock’s short-term average relative to its long-term measure. A MACD -a reading above the zero line means that the short-term is above the long-term average. This scenario implies that there is an upward momentum. The opposite is true when the MACD falls below the zero-line.
Analysts at Maxim Group assigned TLSA a rating of Buy in their intiating review released on December 17.
The average rating for the TLSA equity is 2 and is currently gathering a bullish momentum. Of 1 analysts tracking Tiziana Life Sciences PLC polled by Reuters, 0 rated TLSA as a hold. The remaining 1 analysts were split evenly. However, the split wasn’t equal as a majority (1) rated it as a buy or strong buy. 0 analyst advised investors against buying the stock or to sell if they own any of the stock.
Elsewhere, the TLSA stock price is 0X ahead of its 12-month Consensus earnings per share estimates.